{"nct_id":"NCT00752427","title":"24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia","status":"COMPLETED","status_verified_date":"2010-04","start_date":"2004-06","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2005-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}